Vimarsana
Biggest News Aggregation in the World

Wayne Lautt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Wayne Lautt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Wayne Lautt Today - Breaking & Trending Today

Biotech outside the box – Winnipeg Free Press - Vimarsana News

Biotech outside the box – Winnipeg Free Press

Breaking News, Sports, Manitoba, Canada

DMAC Stock Price | Diamedica Therapeutics Inc. Stock Quote (U.S.: Nasdaq) - Vimarsana News

DMAC Stock Price | Diamedica Therapeutics Inc. Stock Quote (U.S.: Nasdaq)

DMAC | Complete Diamedica Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Short Interest in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Drops By 5.6% - Vimarsana News

Short Interest in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Drops By 5.6%

DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Get Rating) was the target of a significant drop in short interest in April. As of April 30th, there was short interest totalling 91,900 shares, a drop of 5.6% from the April 15th total of 97,400 shares. Based on an average daily trading volume, of 27,100 shares, the days-to-cover ratio […]

Head-To-Head Analysis: Marinus Pharmaceuticals (NASDAQ:MRNS) & DiaMedica Therapeutics (NASDAQ:DMAC) - Vimarsana News

Head-To-Head Analysis: Marinus Pharmaceuticals (NASDAQ:MRNS) & DiaMedica Therapeutics (NASDAQ:DMAC)

DiaMedica Therapeutics (NASDAQ:DMAC – Get Rating) and Marinus Pharmaceuticals (NASDAQ:MRNS – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, risk, profitability, dividends and valuation. Volatility and Risk DiaMedica Therapeutics has a beta of […]

Head to Head Contrast: DiaMedica Therapeutics (NASDAQ:DMAC) and 9 Meters Biopharma (NASDAQ:NMTR) - Vimarsana News

Head to Head Contrast: DiaMedica Therapeutics (NASDAQ:DMAC) and 9 Meters Biopharma (NASDAQ:NMTR)

DiaMedica Therapeutics (NASDAQ:DMAC – Get Rating) and 9 Meters Biopharma (NASDAQ:NMTR – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership. Analyst Ratings This is a breakdown of current […]